Tournus, France

Isabelle Meunier


Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 26(Granted Patents)


Company Filing History:


Years Active: 1995-1996

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Isabelle Meunier

Introduction

Isabelle Meunier is a prominent inventor based in Tournus, France. She has made significant contributions to the field of chemistry, particularly in the development of novel compounds with enhanced properties. With a total of 2 patents, her work has garnered attention in both academic and industrial circles.

Latest Patents

Isabelle's latest patents include "Alkyl ether analogues of benzoporphyrin derivatives," which describe compounds that exhibit superior properties compared to known photosensitizers. These compounds are defined by a specific chemical formula that includes various R groups, showcasing her innovative approach to enhancing photosensitizer efficacy. Another notable patent is for a "Process for the synthesis of cyclic polynitrogenated compounds." This method involves the synthesis of cyclic polyamines through a unique reaction process, utilizing a Raney alloy instead of traditional hydrogen under pressure methods. The compounds produced from this process have versatile applications in various chemical fields.

Career Highlights

Throughout her career, Isabelle has worked with reputable organizations such as Health Research, Inc. and the University of California. Her experience in these institutions has allowed her to collaborate with leading experts in her field and contribute to groundbreaking research.

Collaborations

Isabelle has collaborated with notable colleagues, including Ravindra Kumar Pandey and Thomas J Dougherty. These partnerships have further enriched her research and expanded the impact of her inventions.

Conclusion

Isabelle Meunier's innovative work in chemistry and her contributions to the development of new compounds highlight her role as a leading inventor. Her patents reflect her commitment to advancing scientific knowledge and improving existing technologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…